
Revolution Medicines, Inc.
USD155.99
+4.68 (+3.09%)
CEO
Mark A. Goldsmith
IPO Date
2020-02-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$151.56
Prev. Close
$151.31
Day Low
$151.42
Day High
$156.86
52W Low
$34.00
52W High
$166.50
Market Cap
$33.16B
Volume
2.00M
| 7 May 2026 |
| Guggenheim |
| Buy |
| Buy |
| maintain |
| 7 May 2026 | RBC Capital | Outperform | Outperform | maintain |
| 7 May 2026 | Wedbush | Outperform | Outperform | maintain |
| 7 May 2026 | Needham | Buy | Buy | maintain |
| 22 Apr 2026 | HC Wainwright & Co. | Buy | Buy | maintain |
| 22 Apr 2026 | Leerink Partners | Outperform | Outperform | maintain |
| 20 Apr 2026 | Needham | Buy | Buy | maintain |